LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

LLY

1,042.36

-1.13%↓

JNJ

210.54

+0.48%↑

ABBV

224.13

+0.08%↑

UNH

331.16

-0.89%↓

AZN

89.91

-1.6%↓

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

17 dec. 2025, 23:50 UTC

Acțiuni populare

Stocks to Watch: Micron, MillerKnoll, HireQuest, Insmed

17 dec. 2025, 23:20 UTC

Câștiguri

Correction to Micron Logs Sales Jump Article

17 dec. 2025, 23:07 UTC

Câștiguri

Micron Logs Sales Jump, Sees Further Growth as AI Demand Outpaces Supply -- Update

17 dec. 2025, 21:37 UTC

Câștiguri

Micron Technology 1Q Sales Jump 57%, Led By Memory Growth

17 dec. 2025, 23:53 UTC

Market Talk

Gold Edges Higher, Supported by Some Tailwinds -- Market Talk

17 dec. 2025, 23:43 UTC

Market Talk

Nikkei May Fall, Tracking Wall Street's Decline -- Market Talk

17 dec. 2025, 23:06 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Transaction Expected to Be Closed in 2H of Calendar Year 2026

17 dec. 2025, 23:05 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Currently No Plans of Issuing New Shares in Asahi

17 dec. 2025, 23:04 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Funds to Be Provided Via Borrowings From Financial Institutions or Cash on Hand

17 dec. 2025, 23:03 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Acquisition of 53.68% Stake in UDV (Kenya) is $646M on Equity Value Basis

17 dec. 2025, 23:02 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Acquisition of 100% Stake in Diageo Kenya is $2.354B on Equity Value Basis

17 dec. 2025, 22:59 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Deal Part of Strategy Under Medium- to Long-Term Management Policy

17 dec. 2025, 22:57 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: To Indirectly Acquire 65.00% Stake in East African Breweries PLC

17 dec. 2025, 22:56 UTC

Achiziții, Fuziuni, Preluări

Asahi Group: Stakes Acquired From Two Subsidiaries of Diageo Plc

17 dec. 2025, 22:55 UTC

Achiziții, Fuziuni, Preluări

Asahi Group Holdings: To Acquire 100% Stake in Diageo Kenya Ltd., 53.68% Stake in UVD (Kenya) Ltd.

17 dec. 2025, 22:49 UTC

Market Talk

Sandfire Resources Production Pipeline Strength Questioned -- Market Talk

17 dec. 2025, 21:58 UTC

Câștiguri

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:50 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Tech, Media & Telecom Roundup: Market Talk

17 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 dec. 2025, 21:46 UTC

Câștiguri

Salesforce and Other AI Stocks That Can Catch Up to the Pack -- Barrons.com

17 dec. 2025, 21:20 UTC

Câștiguri

Micron Crushes Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:10 UTC

Câștiguri

Micron Beats Earnings. The Stock Is Rising. -- Barrons.com

17 dec. 2025, 21:05 UTC

Câștiguri

Micron Technology Anticipates Business Performance to Continue Strengthening Through FY26

17 dec. 2025, 21:04 UTC

Câștiguri

Micron Technology: 2Q Outlook Reflects Substantial Records Across Rev, Gross Margin, EPS and Free Cash Flow >MU

17 dec. 2025, 21:04 UTC

Câștiguri

Micron Technology Sees 2Q Oper Expenses $1.56B, Plus or Minus $20M >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q Adj EPS $8.42, Plus or Minus 20c >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q EPS $8.19, Plus or Minus 20c >MU

17 dec. 2025, 21:03 UTC

Câștiguri

Micron Technology Sees 2Q Revenue $18.7B, Plus or Minus $400M >MU

17 dec. 2025, 21:02 UTC

Câștiguri

Micron Technology 1Q Operating Cash Flow $8.41 B >MU

17 dec. 2025, 21:01 UTC

Câștiguri

Micron Technology 1Q Rev $13.64B >MU

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat